Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers

NCT04209660 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma
Salivary Gland Cancer

Interventions

DRUG: Lenvatinib
DRUG: Pembrolizumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]